You are here: Industry Insights > Australia

News List

Incidence of End-Stage Kidney Disease Up in Australia drugs
January 02, 2019
For nonindigenous people with type 2 diabetes mellitus (T2DM) in Australia, the age-standardized incidence of end-stage kidney disease (ESKD) increased from 2002 to 2013....
Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye b3cnewswire
November 19, 2018
Bionic Vision Technologies Pty Ltd (BVT) today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
Vertex announces reimbursement agreement in Australia for ORKAMBI biospectrumasia
September 29, 2018
Australians with CF join thousands of patients worldwide who are already receiving lumacaftor/ivacaftor
Pharmaceutical opioids lead to more overdose deaths in Australia pharmaceutical
August 22, 2018
A new report by University of New South Wales (UNSW Sydney) National Drug and Alcohol Research Centre has revealed that pharmaceutical opioids are major cause for associated overdose deaths.
Vertex’s Orkambi CF drug okayed for funding in Australia pharmaphorum
August 21, 2018
Vertex’s Orkambi (lumacaftor+ivacaftor) cystic fibrosis drug is to be reimbursed in Australia’s publicly funded health system after it was cleared by a cost-effectiveness committee.
Australia gives its nod to Trastuzumab Biosimilar biospectrumasia
August 10, 2018
The trastuzumab biosimilar will join 2 other anticancer biosimilars on the list of TAG’s approved biosimilars.
Australian Stem Cell Researchers Receive $3 Million Funding biospectrumasia
August 02, 2018
Stem Cells Australia’s expert team of doctors and scientists will be supported by partnerships with key Australian charities including Genetic Cures Australia and HeartKids.
Glenmark to commercialise Ryaltris in Australia, NZ biospectrumasia
July 09, 2018
Glenmark will receive an upfront payment as well as regulatory and commercial milestone payments from Seqirus.
Suven gets product patents by Australia, Singapore financialexpress
May 21, 2018
Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for treatment of disorders associated with neurodegenerative diseases.
Australia allocates $393 M to Nanotechnology & Genomics biospectrumasia
May 16, 2018
The government response states the public benefit of the research will include: improving weather forecasts...

Previous page 1 2 3 4 5 6 Next page